SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-160660
Filing Date
2012-04-12
Accepted
2012-04-12 16:05:09
Documents
4
Period of Report
2012-05-22
Effectiveness Date
2012-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d330212ddef14a.htm DEF 14A 580257
2 GRAPHIC g330212g45h63.jpg GRAPHIC 12725
3 GRAPHIC g330212g76q95.jpg GRAPHIC 7377
4 GRAPHIC g330212pc_pg002.jpg GRAPHIC 5151
  Complete submission text file 0001193125-12-160660.txt   616527
Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Filer) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34828 | Film No.: 12756565
SIC: 2834 Pharmaceutical Preparations